NeoPharm CO., LTD. (KOSDAQ:092730)

NeoPharm CO., LTD. Revenue

NeoPharm CO., LTD. had revenue of 31.61B KRW in the quarter ending March 31, 2025, with 12.03% growth. This brings the company's revenue in the last twelve months to 122.41B, up 20.32% year-over-year. In the year 2024, NeoPharm CO., LTD. had annual revenue of 119.01B with 22.56% growth.

• Revenue (ttm): 122.41B
• Revenue Growth: +20.32%
• P/S Ratio: 2.40
• Revenue / Employee: 711.67M
• Employees: 172
• Market Cap: 294.37B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	119.01B	21.91B	22.56%
Dec 31, 2023	97.10B	12.07B	14.20%
Dec 31, 2022	85.03B	-2.90B	-3.30%
Dec 31, 2021	87.93B	6.31B	7.72%
Dec 31, 2020	81.63B	-1.61B	-1.94%